Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes

Clinical trial NCT00094991 · COMPLETED

Trial details

NCT number: NCT00094991
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2004-05-01
Primary completion: 2006-05-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.